Clinical characteristics and mortality risk in relation to obstructive and central sleep apnoea in community-dwelling elderly individuals: A 7-year follow-up

Age and Ageing

Volumn 41, Issue 4, 2012, Pages 468-474

  Johansson, Peter ^a   Alehagen, Urban ^a,b   Svanborg, Eva ^a,b   Dahlström, Ulf ^a,b   Broström, Anders ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Central sleep apnoea; Elderly; Mortality; Obstructive sleep apnoea

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; CLINICAL EXAMINATION; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RURAL POPULATION; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SYSTOLIC DYSFUNCTION; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDEPENDENT LIVING; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SLEEP; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE; STROKE VOLUME; SWEDEN; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

OSA;

EID: 84864006418     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs019     Document Type: Article

References (29)

1. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
2. Bradley TD, Floras JS. Sleep apnea and heart failure: part II: central sleep apnea. Circulation 2003; 107: 1822-6.
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
4. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a populationbased sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 685-9.
5. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144-8.
6. Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003; 107: 1671-8.
7. Nieto FJ, Young TB, Lind BK et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829-36.
8. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EMLorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007; 131: 1379-86.
9. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.
10. Johansson P, Alehagen U, Svanborg E, Dahlstrom U, Brostrom A. Sleep disordered breathing in an elderly community-living population: relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 2009; 10: 1005-11.
11. Ancoli-Israel S, DuHamel ER, Stepnowsky C, Engler R, Cohen-Zion M, Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest 2003; 124: 1400-5.
12. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007; 49: 2028-34.
13. Alehagen U, Goetze JP, Dahlstrom U. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly. Clin Chim Acta 2007; 382: 8-14.
14. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004; 66: 411-21.
15. Alehagen U, Lindstedt G, Eriksson H, Dahlstrom U. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 2003; 49: 1337-46.
16. Alehagen U, Dahlstrom U. Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure. Int J Cardiol 2009; 133: 233-40.
17. Young T, Shahar E, Nieto FJ et al. Predictors of sleepdisordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893-900.
18. Haas DC, Foster GL, Nieto FJ et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005; 111: 614-21.
19. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009; 33: 1467-84.
20. Ryan S, McNicholas WT. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 2008; 114: 261-6.
21. Sun M, Chen M, Dawood F et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007; 115: 1398-407.
22. Ferrier K, Campbell A, Yee B et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005; 128: 2116-22.
23. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007; 9: 251-7.
24. Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sanchez-Armengol A, Martinez-Martinez A, Capote F. Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest 2005; 127: 1667-73.
25. Christ M, Sharkova Y, Fenske H et al. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients. Int J Cardiol 2007; 116: 62-9.
26. Ancoli-Israel S, Kripke DF, Klauber MR et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 1996; 19: 277-82.
27. Mant A, King M, Saunders NA, Pond CD, Goode E, Hewitt H. Four-year follow-up of mortality and sleep-related respiratory disturbance in non-demented seniors. Sleep 1995; 18: 433-8.
28. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009; 6: e1000132.
29. Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115: 3173-80.